Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive genetic testing in amyotrophic lateral sclerosis (ALS): Experiences of decision-making and engagement with UK genetic counseling services.

Journal of genetic counseling·2026
Same author

Limited data capture on reproductive medicine use in amyotrophic lateral sclerosis: implications for monitoring access.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2026
Same author

Advancing genomic medicine: Guidelines, risk scores, and disease discovery.

European journal of human genetics : EJHG·2026
Same author

Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience.

Journal of neurology·2025
Same author

Genomic sequencing technologies for rare disease in mainstream healthcare: the current state of implementation.

European journal of human genetics : EJHG·2025
Same author

The use of genetic testing in amyotrophic lateral sclerosis (ALS): a practical approach.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2025

Related Experiment Video

Updated: Jun 2, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Neurodegeneration with brain iron accumulation.

Alisdair McNeill1, Patrick F Chinnery

  • 1Department of Clinical Neurosciences, UCL Institute of Neurology, London, UK.

Handbook of Clinical Neurology
|April 19, 2011
PubMed
Summary

Neurodegenerative disorders with brain iron accumulation (NBIA) are genetic conditions causing neurodegeneration and excess brain iron. Diagnosis relies on MRI, with varied treatment responses, highlighting the need for early identification.

More Related Videos

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Jun 2, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Area of Science:

  • Neurology
  • Genetics
  • Radiology

Background:

  • Neurodegenerative disorders with brain iron accumulation (NBIA) represent a heterogeneous group of genetic and acquired conditions.
  • Elevated brain iron characterizes NBIA, leading to neurodegeneration with diverse clinical presentations.
  • Key genetic forms include neuroferritinopathy, aceruloplasminemia, pantothenate kinase-associated neurodegeneration (PKAN), and infantile neuroaxonal dystrophy (INAD).

Purpose of the Study:

  • To review the clinical and genetic heterogeneity of NBIA.
  • To highlight diagnostic approaches, particularly the role of brain MRI.
  • To discuss therapeutic strategies and their efficacy across different NBIA subtypes.

Main Methods:

  • Literature review of NBIA, focusing on genetic causes, clinical features, and diagnostic imaging.
  • Analysis of phenotypic overlap and differentiation between NBIA subtypes.
  • Evaluation of treatment outcomes for iron depletion therapy in various NBIA forms.

Main Results:

  • NBIA encompasses disorders like neuroferritinopathy, aceruloplasminemia, PKAN, and INAD, often with overlapping symptoms.
  • Brain MRI is crucial for detecting iron deposition and aiding genotypic distinction.
  • Iron depletion therapy is effective for aceruloplasminemia but not for neuroferritinopathy, PKAN, or INAD.

Conclusions:

  • Accurate diagnosis of NBIA requires a high index of suspicion due to overlapping symptoms with common neurological disorders.
  • Brain MRI is a key diagnostic tool for identifying iron accumulation and guiding genetic investigations.
  • Therapeutic success in NBIA is genotype-dependent, emphasizing the need for tailored treatment approaches.